ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Labor Issues/Antitrust/Workplace LBR
Legislation granting independent pharmacists collective bargaining rights.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Medicare/Medicaid MMM
Proposed changes to the Medicare Part D prescription drug benefit. Adjustment to Medicaid prescription drug reimbursement rates.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| LAUREN LEA FULLER | Chief INvestigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Health Issues HCR
Health care reform with respect to pharmacy issues and the professional role of pharmacists; increased federal funding for comparative effectiveness research; establishment of a public-private entity to coordinate comparative effetiveness research; legislation relations to health information technology and elecrtonic prescribing; appropriations for U.S. Food and Drug Administration and the Agency for Healthcare Research and Quality.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| LAUREN LEA FULLER | Chief Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Pharmacy PHA
Health care reform with respect to pharmacy issues and the professional role of pharmacists; legislation relating to medication therapy management programs; legislation relating to importation of prescription drugs; legislation granting the FDA authority to approve follow-on biologic products; legislation relating to settlement agreements between brand-name and generic manufacturers; legislation promoting the use of generic drugs generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MELISSA ANDEL | — |
| LAUREN LEA FULLER | Cheif Investigative Counsel, Sen. Finance Cmte. |
| WILLIAM HERMELIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.